An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen

Saved in:
Bibliographic Details
Published inAIDS patient care and STDs Vol. 22; no. 4; p. 263
Main Authors Pierone, Jr, Gerald, Mieras, Jeffrey, Bulgin-Coleman, Dorothy, Kantor, Chandra, Shearer, James, Fontaine, Lunie, Fath, Michael
Format Journal Article
LanguageEnglish
Published United States 01.04.2008
Subjects
Adenine - administration & dosage
Adenine - analogs & derivatives
Adenine - therapeutic use
Adult
Anti-HIV Agents - administration & dosage
Anti-HIV Agents - therapeutic use
Drug Therapy, Combination
HIV Infections - drug therapy
HIV Infections - virology
HIV-1 - drug effects
Humans
Lopinavir
Middle Aged
Organophosphonates - administration & dosage
Organophosphonates - therapeutic use
Pilot Projects
Pyrimidinones - administration & dosage
Pyrimidinones - therapeutic use
Reverse Transcriptase Inhibitors - administration & dosage
Reverse Transcriptase Inhibitors - therapeutic use
Ritonavir - administration & dosage
Ritonavir - therapeutic use
RNA, Viral - blood
Tenofovir
Treatment Outcome
Online AccessGet more information

Cover

More Information
ISSN:1557-7449
DOI:10.1089/apc.2007.0148